Ossiam Viatris Inc Transaction History

Ossiam

$5.65 Billion
Q1 2024

A detailed history of Ossiam transactions in Viatris Inc stock. As of the latest transaction made, Ossiam holds 24,533 shares of VTRS stock, worth $254,652. This represents 0.01% of its overall portfolio holdings.

Number of Shares

24,533

Holding current value

$254,652

% of portfolio

0.01%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$11.27 - $13.53 $276,486 - $331,931	24,533 New	24,533 $292,000
Q1 2023 May 12, 2023	BUY	$9.2 - $12.26 $556,848 - $742,061	60,527 New	60,527 $582,000
Q2 2022 Aug 12, 2022	SELL	$9.95 - $12.27 $377,592 - $465,634	-37,949 Reduced 66.82%	18,847 $197,000
Q1 2022 May 13, 2022	SELL	$9.81 - $15.4 $907,218 - $1.42 Million	-92,479 Reduced 61.95%	56,796 $618,000
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $1.51 Million - $1.83 Million	124,655 Added 506.32%	149,275 $2.02 Million

Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $435,869 - $542,736	-33,606 Reduced 57.72%	24,620 $346,000
Q1 2021 May 17, 2021	SELL	$13.59 - $18.54 $1.21 Million - $1.65 Million	-88,866 Reduced 60.42%	58,226 $813,000
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $2.1 Million - $2.76 Million	147,092 New	147,092 $2.76 Million

Others Institutions Holding VTRS

# of Institutions

1,099

Shares Held

945M

Call Options Held

3.49M

Put Options Held

2.6M

Vanguard Group Inc Valley Forge, PA

142M
Shares

$1.47 Billion
0.03% of portfolio
Black Rock Inc. New York, NY

93.3M
Shares

$969 Million
0.03% of portfolio
State Street Corp Boston, MA

62.8M
Shares

$651 Million
0.03% of portfolio
Price T Rowe Associates Inc Baltimore, MD

57.9M
Shares

$601 Million
0.08% of portfolio
Chris Davis Davis Selected Advisers | Tucson, Az

57.5M
Shares

$596 Million
3.85% of portfolio

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $12.6B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.

Account